Amid the turbulence of the wider global economy in recent years, the pharmaceuticals industry is weathering its own storms. The rising cost of raw materials and supply chain disruptions are squeezing margins as pharma companies face intense pressure—including from countries like the US—to control drug costs. At the same time, a wave of expiring patents threatens… Read More
Transforming commercial pharma with agentic AI
Amid the turbulence of the wider global economy in recent years, the pharmaceuticals industry is weathering its own storms. The rising cost of raw materials and supply chain disruptions are squeezing margins as pharma companies face intense pressure—including from countries like the US—to control drug costs. At the same time, a wave of expiring patents threatens…
Related Posts
The AI Hype Index: Data centers’ neighbors are pivoting to power blackouts
Separating AI reality from hyped-up fiction isn’t always easy. That’s why we’ve created the AI…
Lincoln Lab unveils the most powerful AI supercomputer at any US university
Optimized for generative AI, TX-GAIN is driving innovation in biodefense, materials discovery, cybersecurity, and other…
DeepSeek may have found a new way to improve AI’s ability to remember
An AI model released by Chinese AI company DeepSeek uses new techniques that could significantly…